DNA X, Inc. (SONM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20M 40M 60M Q1 '18: 18.2M Q2 '18: 31.4M Q3 '18: 39.5M Q4 '18: 46.5M Q1 '19: 26.5M Q2 '19: 43.7M Q3 '19: 28.9M Q4 '19: 17.2M Q1 '20: 12.7M Q2 '20: 21.1M Q3 '20: 14.4M Q4 '20: 15.8M Q1 '21: 12.2M Q2 '21: 12M Q3 '21: 14.4M Q4 '21: 15.9M Q1 '22: 13.3M Q2 '22: 12M Q3 '22: 20.5M Q4 '22: 24.1M Q1 '23: 25.8M Q2 '23: 26.8M Q3 '23: 27.6M Q4 '23: 13.4M Q1 '24: 9.1M Q2 '24: 11.5M Q3 '24: 15M Q4 '24: 15.3M Q1 '25: 16.7M Q2 '25: 11.2M Q3 '25: 16.2M Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25

Gross Profit Quarterly

-7M 0 7M 14M 21M Q1 '18: 5.3M Q2 '18: 10.5M Q3 '18: 14.1M Q4 '18: 18.2M Q1 '19: 9M Q2 '19: 14.4M Q3 '19: 6.9M Q4 '19: 4.2M Q1 '20: 2.2M Q2 '20: 4.9M Q3 '20: 4.4M Q4 '20: 3.7M Q1 '21: 2.5M Q2 '21: 2.7M Q3 '21: 1.8M Q1 '22: 1.5M Q2 '22: 2.8M Q3 '22: 3.3M Q4 '22: 3.9M Q1 '23: 4.2M Q2 '23: 4.4M Q3 '23: 5.6M Q4 '23: 5.1M Q1 '24: 2.9M Q2 '24: 3M Q3 '24: 4.2M Q4 '24: -183K Q1 '25: 8.4M Q2 '25: 845K Q3 '25: 1.8M Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25

Operating Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '18: -4M Q2 '18: 596K Q3 '18: 3.3M Q4 '18: 5.5M Q1 '19: -4.1M Q2 '19: -4.6M Q3 '19: -6.3M Q4 '19: -7.4M Q1 '20: -9.1M Q2 '20: -6.6M Q3 '20: -6.1M Q4 '20: -7.5M Q1 '21: -9.1M Q2 '21: -6.5M Q3 '21: -10.7M Q4 '21: -11.7M Q1 '22: -7.1M Q2 '22: -4.2M Q3 '22: -1.9M Q4 '22: -1.1M Q1 '23: 333K Q2 '23: 747K Q3 '23: 688K Q1 '24: -2.7M Q2 '24: -6.5M Q3 '24: -2.4M Q4 '24: 8.4M Q1 '25: -870K Q2 '25: -1.5M Q3 '25: -4M Q4 '25: 915K Q1 '26: -3.6M Q2 '26: -1.3M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Net Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q1 '18: -5.1M Q2 '18: -123K Q3 '18: 2.1M Q4 '18: 4.3M Q1 '19: -5.1M Q2 '19: -5.6M Q3 '19: -6.8M Q4 '19: -8.3M Q1 '20: -10M Q2 '20: -7.1M Q3 '20: -6.5M Q4 '20: -6.4M Q1 '21: -9.3M Q2 '21: -6.7M Q3 '21: -10.9M Q4 '21: -11.7M Q1 '22: -7.2M Q2 '22: -4.2M Q3 '22: -1.6M Q4 '22: -1M Q1 '23: 227K Q2 '23: 509K Q3 '23: 527K Q1 '24: -2.9M Q2 '24: -6.6M Q3 '24: -2.5M Q4 '24: -21.6M Q1 '25: 458K Q2 '25: -7.5M Q3 '25: -4.8M Q4 '25: -8.9M Q1 '26: 6.3M Q2 '26: -1.2M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 10M 20M 30M Q1 '18: 12.9M Q2 '18: 20.9M Q3 '18: 25.4M Q4 '18: 28.3M Q1 '19: 17.5M Q2 '19: 29.3M Q3 '19: 22M Q4 '19: 13M Q1 '20: 10.5M Q2 '20: 16.1M Q3 '20: 10M Q4 '20: 12.1M Q1 '21: 9.8M Q2 '21: 9.3M Q3 '21: 12.7M Q4 '21: 16.4M Q1 '22: 11.7M Q2 '22: 9.1M Q3 '22: 17.2M Q4 '22: 20.2M Q1 '23: 21.6M Q2 '23: 22.4M Q3 '23: 22M Q4 '23: 8.3M Q1 '24: 13.9M Q2 '24: 8.5M Q3 '24: 10.8M Q4 '24: 15.2M Q1 '25: 8.4M Q2 '25: 10.3M Q3 '25: 14.4M Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '18: -4.7M Q2 '18: -207K Q3 '18: 2.9M Q4 '18: 5.8M Q1 '19: -4.5M Q2 '19: -30.3M Q3 '19: 6M Q4 '19: -4.7M Q1 '20: 1.1M Q2 '20: 4.6M Q3 '20: -6.4M Q4 '20: -9.8M Q1 '21: -8.2M Q2 '21: -7M Q3 '21: -5.7M Q4 '21: -17.6M Q1 '22: -609K Q2 '22: 765K Q3 '22: -10.3M Q4 '22: -2.2M Q1 '23: -4.2M Q2 '23: 820K Q3 '23: -304K Q4 '23: -351K Q1 '24: -168K Q2 '24: -3.4M Q3 '24: -417K Q4 '24: -4.5M Q1 '25: -9.6M Q2 '25: -4.9M Q3 '25: -7M Q4 '25: -2M Q1 '26: -3.5M Q2 '26: -2M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '18: -4.7M Q2 '18: -393K Q3 '18: 2.7M Q4 '18: 5.6M Q1 '19: -4.6M Q2 '19: -30.4M Q3 '19: 5.3M Q4 '19: -4.8M Q1 '20: 891K Q2 '20: 4.6M Q3 '20: -6.4M Q4 '21: -17.6M Q1 '22: -612K Q2 '22: 762K Q3 '22: -10.3M Q4 '22: -2.2M Q3 '23: -305K Q4 '23: -363K Q1 '24: -198K Q2 '24: -3.4M Q3 '24: -554K Q4 '24: -4.5M Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q1 '22 Q4 '22 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '21: 6.6M Q2 '21: 6.7M Q3 '21: 8.4M Q1 '22: 19.1M Q2 '22: 19.3M Q3 '22: 36.1M Q1 '23: 41.1M Q2 '23: 4.5M Q3 '23: 4.4M Q1 '24: 4.4M Q2 '24: 4.7M Q3 '24: 269.4K Q1 '25: 324.4K Q2 '25: 528.4K Q3 '25: 984.9K Q1 '26: 1.3M Q2 '26: 1.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '18: -2.57 Q1 '19: 4.88 Q2 '19: 7.58 Q3 '19: 8.16 Q4 '19: -1.38 Q1 '20: -1.54 Q2 '20: -1.45 Q3 '20: -2.10 Q4 '20: -2.20 Q1 '21: -3.12 Q2 '22: -2.27 Q3 '22: -1.00 Q4 '22: -0.49 Q1 '23: -0.10 Q2 '23: 0.23 Q3 '23: 0.39 Q4 '24: -93.25 Q1 '25: -91.19 Q2 '25: -103.93 Q3 '25: -99.44 Q4 '25: -27.01 Q1 '26: -23.41 Q2 '26: -10.18 Q1 '19 Q4 '19 Q3 '20 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.